Scholarlink

Background <p>Anal canal carcinoma (ACC) is reported to be a rare cancer worldwide. In Japan, while the incidence rate is similarly low compared to Western countries, its histological distribution differs. This paper aimed to clarify the epidemiological characteristics of ACC, particularly anal canal squamous cell carcinoma (SCC), in Japan and to compare them with Western data.</p> Methods <p>The epidemiological data were taken from the Japanese Society for Cancer of the Colon and Rectum (JSCCR) registry and a nationwide multi-institutional study. Clinicopathological features, human papillomavirus (HPV) status, treatment trends, and survival were analyzed. The comparative data were derived from major Western registry studies.</p> Results <p>In Japan, adenocarcinoma accounted for 66.8–75.5% of the ACC cases, while SCC represented only 16.2–24.4%, in contrast to the 70–85% SCC predominance reported in Western countries. Among Japanese SCC cases, women accounted for 71.5%, a higher proportion than in Western countries. HPV was positive in 85% of the SCC cases, with HPV-16 as the most prevalent genotype, which is consistent with global patterns. The adoption of chemoradiotherapy (CRT) increased from 14% in the 1990&#xa0;s to over 80% after 2010, achieving survival outcomes comparable to surgery.</p> Conclusions <p>In Japan, adenocarcinoma was the predominant type of ACC, while SCC was less common. However, the characteristics of HPV-associated SCC were similar to those observed in Western countries. Standardization of classification and staging criteria and the expansion of HPV vaccination may be essential to improve clinical management and facilitate international comparisons.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cancer epidemiology in rare and hereditary colorectal diseases 2) anal canal cancer (cancer statistics)

  • 期刊论文

  • 发表日期：

    2025年12月26日

查看全文
  • Kazutaka Yamada,
  • Yasumitsu Saiki,
  • Shota Takano,
  • Masafumi Tanaka,
  • Mitsuko Fukunaga,
  • Yasushi Nakamura,
  • Keisuke Yonemura,
  • Kosuke Sugimoto,
  • Yuki Iwasaki,
  • Yoriyuki Tsuji,
  • Masahiro Takano

摘要

Background

Anal canal carcinoma (ACC) is reported to be a rare cancer worldwide. In Japan, while the incidence rate is similarly low compared to Western countries, its histological distribution differs. This paper aimed to clarify the epidemiological characteristics of ACC, particularly anal canal squamous cell carcinoma (SCC), in Japan and to compare them with Western data.

Methods

The epidemiological data were taken from the Japanese Society for Cancer of the Colon and Rectum (JSCCR) registry and a nationwide multi-institutional study. Clinicopathological features, human papillomavirus (HPV) status, treatment trends, and survival were analyzed. The comparative data were derived from major Western registry studies.

Results

In Japan, adenocarcinoma accounted for 66.8–75.5% of the ACC cases, while SCC represented only 16.2–24.4%, in contrast to the 70–85% SCC predominance reported in Western countries. Among Japanese SCC cases, women accounted for 71.5%, a higher proportion than in Western countries. HPV was positive in 85% of the SCC cases, with HPV-16 as the most prevalent genotype, which is consistent with global patterns. The adoption of chemoradiotherapy (CRT) increased from 14% in the 1990 s to over 80% after 2010, achieving survival outcomes comparable to surgery.

Conclusions

In Japan, adenocarcinoma was the predominant type of ACC, while SCC was less common. However, the characteristics of HPV-associated SCC were similar to those observed in Western countries. Standardization of classification and staging criteria and the expansion of HPV vaccination may be essential to improve clinical management and facilitate international comparisons.